TOSO interacts with SYK and enhances BCR pathway activation in chronic lymphocytic leukemia

TOSO interacts with SYK and enhances BCR pathway activation in chronic lymphocytic leukemia

Abstract. Background. TOSO, also named Fas inhibitory molecule 3 (FAIM3), has recently been identified as an immunoglobulin M (IgM) Fc receptor (FcμR). Previous studies have shown that TOSO is specifically over-expressed in chronic lymphocytic leukemia (CLL). However, the functions of TOSO in CLL re...

Full description

Bibliographic Details
Main Authors: Yan-Ru Zhang, Zhen Yu, Wen-Jie Xiong, Xu-Xiang Liu, Hui-Min Liu, Rui Cui, Qi Wang, Wen-Ming Chen, Lu-Gui Qiu, Shu-Hua Yi, Peng Lyu.
Format: Article
Language:English
Published: Wolters Kluwer 2020-09-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000000999

Similar Items

Similar Items